{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T03:43:05Z","timestamp":1773027785855,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.vaccine.2007.11.067","type":"journal-article","created":{"date-parts":[[2007,12,19]],"date-time":"2007-12-19T16:27:00Z","timestamp":1198081620000},"page":"589-594","source":"Crossref","is-referenced-by-count":26,"title":["Single dose of inactivated Japanese encephalitis vaccine with poly(\u03b3-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus"],"prefix":"10.1016","volume":"26","author":[{"given":"Shigefumi","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Yoshii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyokazu","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takami","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Yamanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2007.11.067_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0264-410X(00)00041-4","article-title":"Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains","volume":"18","author":"Kurane","year":"2000","journal-title":"Vaccine"},{"issue":"3 Suppl","key":"10.1016\/j.vaccine.2007.11.067_bib2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3201\/eid0707.017703","article-title":"Emerging viral diseases of Southeast Asia and the Western Pacific","volume":"7","author":"Mackenzie","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2007.11.067_bib3","first-page":"49","article-title":"Japanese encephalitis as an emerging virus: the emergence and spread of Japanese encephalitis virus in Australasia","volume":"267","author":"Mackenzie","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.067_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/jinf.2001.0802","article-title":"Dengue and other emerging flaviviruses","volume":"42","author":"Solomon","year":"2001","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2007.11.067_bib5","series-title":"Fields virology","first-page":"1153","author":"Gubler","year":"2007"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.067_bib6","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1128\/JVI.79.6.3448-3458.2005","article-title":"Nuclear localization of Japanese encephalitis virus core protein enhances viral replication","volume":"79","author":"Mori","year":"2005","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.067_bib7","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1086\/322968","article-title":"Travel vaccines and elderly persons: review of vaccines available in the United States","volume":"33","author":"Leder","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.067_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1086\/341247","article-title":"Japanese encephalitis vaccine for travelers: exploring the limits of risk","volume":"35","author":"Shlim","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2007.11.067_bib9","unstructured":"Infectious Diseases Surveillance Center. Immunization schedule, Japan 2005 (July 29). Available from: http:\/\/idsc.nih.go.jp\/vaccine\/dschedule\/ImmEN_050729rev.gif."},{"issue":"9284","key":"10.1016\/j.vaccine.2007.11.067_bib10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0140-6736(01)05967-0","article-title":"Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case\u2013control study","volume":"358","author":"Bista","year":"2001","journal-title":"Lancet"},{"issue":"9494","key":"10.1016\/j.vaccine.2007.11.067_bib11","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(05)67567-8","article-title":"Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case\u2013control study","volume":"366","author":"Ohrr","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.067_bib12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol Cell Biol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.067_bib13","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.4049\/jimmunol.178.5.2979","article-title":"Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity","volume":"178","author":"Uto","year":"2007","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.11.067_bib14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/mabi.200500036","article-title":"In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly(gamma-glutamic acid)","volume":"5","author":"Akagi","year":"2005","journal-title":"Macromol Biosci"},{"issue":"2\/3","key":"10.1016\/j.vaccine.2007.11.067_bib15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jconrel.2005.08.003","article-title":"Preparation and characterization of biodegradable nanoparticles based on poly(gamma-glutamic acid) with l-phenylalanine as a protein carrier","volume":"108","author":"Akagi","year":"2005","journal-title":"J Control Release"},{"issue":"8","key":"10.1016\/j.vaccine.2007.11.067_bib16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1163\/156856206777996871","article-title":"Multifunctional conjugation of proteins on\/into bio-nanoparticles prepared by amphiphilic poly(gamma-glutamic acid)","volume":"17","author":"Akagi","year":"2006","journal-title":"J Biomater Sci Polym Ed"},{"issue":"23","key":"10.1016\/j.vaccine.2007.11.067_bib17","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1016\/j.biomaterials.2007.04.023","article-title":"Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives","volume":"28","author":"Akagi","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2007.11.067_bib18","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1021\/cm048196f","article-title":"Self-assembled soft nanofibrils of amphipathic polypeptides and their morphological transformation","volume":"17","author":"Kaneko","year":"2005","journal-title":"Chem Mater"},{"key":"10.1016\/j.vaccine.2007.11.067_bib19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1246\/cl.2004.398","article-title":"Stably-dispersed and surface-functional bionanoparticles prepared by self-assembling amphipathic polymers of hydrophilic poly(gamma-glutamic acid) bearing hydrophobic amino acids","volume":"33","author":"Matsusaki","year":"2004","journal-title":"Chem Lett"},{"issue":"31","key":"10.1016\/j.vaccine.2007.11.067_bib20","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1016\/S0264-410X(01)00208-0","article-title":"A purified inactivated Japanese encephalitis virus vaccine made in Vero cells","volume":"19","author":"Srivastava","year":"2001","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2007.11.067_bib21","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1128\/JVI.77.16.8745-8755.2003","article-title":"Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus e protein for a second-generation subunit vaccine","volume":"77","author":"Kojima","year":"2003","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.11.067_bib22","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nm1257","article-title":"Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination","volume":"11","author":"Badovinac","year":"2005","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.vaccine.2007.11.067_bib23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.067_bib24","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.4049\/jimmunol.176.5.2749","article-title":"Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin","volume":"176","author":"Luci","year":"2006","journal-title":"J Immunol"},{"issue":"18","key":"10.1016\/j.vaccine.2007.11.067_bib25","doi-asserted-by":"crossref","first-page":"10009","DOI":"10.1128\/JVI.00489-07","article-title":"Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120","volume":"81","author":"Wang","year":"2007","journal-title":"J Virol"},{"issue":"49","key":"10.1016\/j.vaccine.2007.11.067_bib26","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.1016\/j.vaccine.2007.09.051","article-title":"Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity","volume":"25","author":"Okamoto","year":"2007","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2007.11.067_bib27","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0264-410X(02)00169-X","article-title":"Mechanisms of stimulation of the immune response by aluminum adjuvants","volume":"20","author":"HogenEsch","year":"2002","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.067_bib28","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4049\/jimmunol.177.2.1197","article-title":"GM1 binding-deficient exotoxin is a potent noninflammatory broad spectrum intradermal immunoadjuvant","volume":"177","author":"Zoeteweij","year":"2006","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.11.067_bib29","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1073\/pnas.91.11.4902","article-title":"Stable intrachain and interchain complexes of neurofilament peptides: a putative link between Al3+ and Alzheimer disease","volume":"91","author":"Hollosi","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2007.11.067_bib30","first-page":"431","article-title":"Aluminum and Alzheimer's disease","volume":"146","author":"Spink","year":"1992","journal-title":"CMAJ"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2007.11.067_bib31","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1042\/bj3330833","article-title":"Membrane composition can influence the rate of Al3+-mediated lipid oxidation: effect of galactolipids","volume":"333","author":"Verstraeten","year":"1998","journal-title":"Biochem J"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.067_bib32","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.4049\/jimmunol.100.5.1139","article-title":"Lack of adjuvant effect of A1PO4 on purified influenza virus hemagglutinins in man","volume":"100","author":"Davenport","year":"1968","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.067_bib33","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.4049\/jimmunol.173.5.3310","article-title":"The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues","volume":"173","author":"Eriksson","year":"2004","journal-title":"J Immunol"},{"issue":"5\/6","key":"10.1016\/j.vaccine.2007.11.067_bib34","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0264-410X(01)00412-1","article-title":"Highly purified mutant E112K of cholera toxin elicits protective lung mucosal immunity to diphtheria toxin","volume":"20","author":"Ohmura","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.067_bib35","first-page":"91","article-title":"Immune responses to Japanese encephalitis virus","volume":"267","author":"Kurane","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"issue":"25\/26","key":"10.1016\/j.vaccine.2007.11.067_bib36","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/S0264-410X(03)00382-7","article-title":"Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice","volume":"21","author":"Konishi","year":"2003","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2007.11.067_bib37","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1128\/JVI.73.7.5527-5534.1999","article-title":"The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes","volume":"73","author":"Konishi","year":"1999","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2007.11.067_bib38","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1016\/j.vaccine.2006.12.046","article-title":"A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis","volume":"25","author":"Lyons","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07013837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07013837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T10:31:30Z","timestamp":1684146690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07013837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0264410X07013837"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.11.067","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}